AMHR2 and ovarian serous adenocarcinoma: Previously, it was reported that transgenic mice carrying Amhr2-Cre that induced the deletion of DicerloxP/loxP and PtenloxP/loxP alleles in FT stromal cells developed serous ovarian adenocarcinomas [35].